Can Edible Mushrooms with Antiviral Properties be used for COVID-19 Treatment?
AbstractNot abstract Not abstract Not abstract Not abstract
Li H, Liu SM, Yu XH, Tang SL, Tang CK. Coronavirus disease 2019 (COVID-19): current status and future perspectives. International journal of antimicrobial agents. 2020; 55(5):105951.
Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, Megawati D, Hayati Z, Wagner AL, Mudatsir M. Coronavirus disease 2019 (COVID-19): A literature review. Journal of infection and public health. 2020;13(5):667-73.
COVID19 data. Worldometers. Available from: https://www.worldometers.info/coronavirus/(acessed on september 20, 2021)
Sharma P, Veer K. Action and problems related to the COVID-19 outbreak in India. Infection Control & Hospital Epidemiology. 2020; 41(12):1478-9.
Gao Z, Xu Y, Sun C, Wang X, Guo Y, Qiu S, Ma K. A systematic review of asymptomatic infections with COVID-19. Journal of Microbiology, Immunology and Infection. 2021;54(1):12-6.
Hannah Ritchie, Edouard Mathieu, Lucas Rodés-Guirao, Cameron Appel, Charlie Giattino, Esteban Ortiz-Ospina, Joe Hasell, Bobbie Macdonald, Diana Beltekian and Max Roser (2020) - "Coronavirus Pandemic (COVID-19)". Published online at OurWorldInData.org. Retrieved from: 'https://ourworldindata.org/coronavirus' (Online Resource)
Final report confirms remdesivir benefits for COVID-19, available from https://www.nih.gov/news-events/nih-research-matters/final-report-confirms-remdesivir-benefits-covid-19.( Accessed 20 September 2021)
The COVID-19 Treatment Guidelines, available from https://www.covid19treatmentguidelines.nih.gov/therapies/immunomodulators/corticosteroids/ ( Accessed 20 September 2021).
Shahzad F, Anderson D, Najafzadeh M. The antiviral, anti-inflammatory effects of natural medicinal herbs and mushrooms and SARS-CoV-2 infection. Nutrients. 2020;12(9):2573.
Raut JK. Mushroom: a potent source of natural antiviral drugs. Applied Science and Technology Annals. 2020; 1(1):81-91.
Valverde, María Elena et al. “Edible mushrooms: improving human health and promoting quality life.” International journal of microbiology vol. 2015 (2015):376387.
Seo DJ, Choi C. Antiviral bioactive compounds of mushrooms and their antiviral mechanisms: a review. Viruses. 2021;13 (2):350.
Zhao S, Gao Q, Rong C, Wang S, Zhao Z, Liu Y, Xu J. Immunomodulatory effects of edible and medicinal mushrooms and their bioactive immunoregulatory products. Journal of Fungi. 2020;6(4):269.
How An Immunologist Uses Mushrooms To Help Fight The Cold & Flu. Available from on https://www.mindbodygreen.com/articles/how-immunologist-uses-fungi-to-fight-cold-and-flu.(Acessed 22 April 2021)
Can Maitake Mushrooms Help With Coronavirus (COVID-19)? Available from https://selfhacked.com/blog/maitake-mushrooms-coronavirus/( Accessed on April 2021)
Ren G, Xu L, Lu T, Yin J. Structural characterization and antiviral activity of lentinan from Lentinus edodes mycelia against infectious hematopoietic necrosis virus. International journal of biological macromolecules. 2018;115: 1202-10.
Gioia M, Ciaccio C, Calligari P, De Simone G, Sbardella D, Tundo G, Fasciglione GF, Di Masi A, Di Pierro D, Bocedi A, Ascenzi P. Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches. Biochemical Pharmacology. 2020;182:114225.
Rangsinth P, Sillapachaiyaporn C, Nilkhet S, Tencomnao T, Ung AT, Chuchawankul S. Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach. Journal of traditional and complementary medicine. 2021;11(2):158-72.
Ullrich S, Nitsche C. The SARS-CoV-2 main protease as drug target. Bioorg Med Chem Lett. 2020; 30(17):127377.
Abu-serie, M.M.; Habashy, N.H.; Attia, W.E. In vitro evaluation of the synergistic antioxidant and anti-inflammatory activities of the combined extracts from Malaysian Ganoderma lucidum and Egyptian Chlorella vulgaris. BMC Complement. Altern. Med. 2018;18(1): 1-13.
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation. Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This work is licensed under a Creative Commons license (CC-BY). However, the license permits any user to read, copy, redistribute and and make derivative the material in any medium or format for any purpose, even commercially.